There are other new candidate biomarkers for FMF in the literature.8,23–28 Pentraxin-3, omentin, serum CXC chemokine ligand 16, serum amyloid A, CD144+ and CD146+ as circulating endothelial microparticles, chitotriosidase, S10012A, and resolvin D1 have been investigated and had promising results. This evidence concerns the gene ITLN1 and familial Mediterranean fever.